Welcome to our dedicated page for IACB.U news (Ticker: IACB.U), a resource for investors and traders seeking the latest updates and insights on IACB.U stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IACB.U's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IACB.U's position in the market.
ION Acquisition Corp 2 Ltd. (NYSE: IACB.U) announced that holders of its IPO units can start trading Class A ordinary shares and warrants separately from April 5, 2021. The shares will trade under the symbols "IACB" and "IACB WS" on the NYSE. To separate units, holders must contact Continental Stock Transfer & Trust Company. Registration statements for these securities were effective as of February 10, 2021. The Company is a blank check firm aiming to merge with technology-focused Israeli businesses.
ION Acquisition Corp 2 Ltd. has successfully completed its initial public offering, raising $253 million by selling 25,300,000 units at $10.00 each, including 3,300,000 units from an over-allotment option. Each unit consists of one Class A ordinary share and a redeemable warrant. Trading commenced on NYSE under the ticker symbol IACB.U on February 11, 2021. The company aims to pursue business combinations, focusing on innovative Israeli companies. Goldman Sachs and Morgan Stanley managed the offering, with AmeriVet Securities as co-manager.
ION Acquisition Corp 2 Ltd. announced the pricing of its initial public offering of 22,000,000 units at $10.00 each, set to trade on the NYSE under the ticker symbol IACB.U starting February 11, 2021. Each unit consists of one Class A ordinary share and one-eighth of a redeemable warrant, which can be exercised at $11.50 per share. The offering is expected to close on February 16, 2021. The company aims to target business combinations with Israeli tech firms, sponsored by ION Holdings 2, LP, and is backed by Goldman Sachs & Co. LLC and Morgan Stanley.
